Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.
ENLV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enlivex Therapeutics (ENLV) Earnings Date & Reports

A.I. Advisor
published Earnings

ENLV is expected to report earnings to rise 62.50% to -19 cents per share on December 02

Enlivex Therapeutics ENLV Stock Earnings Reports
Q3'24
Est.
$-0.19
Q2'24
Beat
by $0.03
Q1'24
Est.
$-0.25
Q4'23
Missed
by $0.21
Q3'23
Est.
$-0.32
The last earnings report on August 19 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 12.65K shares outstanding, the current market capitalization sits at 20.89M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ENLV
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For ENLV
(Try 14 days for Free)
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com